• Home
  • Pharmaceuticals and Healthcare
Premature Ejaculation Treatment Market - Global Outlook and Forecast 2021-2027

Premature Ejaculation Treatment Market - Global Outlook and Forecast 2021-2027

Report Code: KNJ759109 | No. of Pages: 90 | Category: Pharmaceuticals and Healthcare
Publisher: Market Monitor Global | Date of Publish: Jun-2021 
The Premature Ejaculation Treatment market report provides the overall market analysis of the industry. This market report presents the current snapshot of the Premature Ejaculation Treatment market to understand the market's key features. The content of the report highlights the important market criteria that help to develop the market further. The report provides the value and the volume of the Premature Ejaculation Treatment at global, regional, and company levels. The historical market value for the year 2021 along with the market value for the upcoming year 2027 has been presented in the market report. Along with that, the report also provides information on subjects such as Export, import, production, and production capacity of the Premature Ejaculation Treatment market.This report contains market size and forecasts of Premature Ejaculation Treatment in Global, including the following market information:
Global Premature Ejaculation Treatment Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Premature Ejaculation Treatment market was valued at 2722.6 million in 2020 and is projected to reach US$ 3819.7 million by 2027, at a CAGR of 8.8% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Premature Ejaculation Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Premature Ejaculation Treatment Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Premature Ejaculation Treatment Market Segment Percentages, By Type, 2020 (%)
Antidepressants(SSRIs)
Phosphodiesterase-5 Inhibitors
Topical Anesthetics
Analgesics
Other Treatment

China Premature Ejaculation Treatment Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Premature Ejaculation Treatment Market Segment Percentages, By Application, 2020 (%)
Hospital
Retail Pharmacy
Online Pharmacy
Other

Global Premature Ejaculation Treatment Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Premature Ejaculation Treatment Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Premature Ejaculation Treatment Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Premature Ejaculation Treatment Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Pfizer
Novartis
Eli Lilly
Johnson & Johnson
GlaxoSmithKline
Bayer
Menarini
Teva
Sunrise Pharma
Regent Pacific
Torrent Pharma
Vivus
1 Introduction to Research & Analysis Reports
    1.1 Premature Ejaculation Treatment Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Premature Ejaculation Treatment Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Premature Ejaculation Treatment Overall Market Size
    2.1 Global Premature Ejaculation Treatment Market Size: 2021 VS 2027
    2.2 Global Premature Ejaculation Treatment Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Premature Ejaculation Treatment Players in Global Market
    3.2 Top Global Premature Ejaculation Treatment Companies Ranked by Revenue
    3.3 Global Premature Ejaculation Treatment Revenue by Companies
    3.4 Top 3 and Top 5 Premature Ejaculation Treatment Companies in Global Market, by Revenue in 2020
    3.5 Global Companies Premature Ejaculation Treatment Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Premature Ejaculation Treatment Players in Global Market
        3.6.1 List of Global Tier 1 Premature Ejaculation Treatment Companies
        3.6.2 List of Global Tier 2 and Tier 3 Premature Ejaculation Treatment Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Premature Ejaculation Treatment Market Size Markets, 2021 & 2027
        4.1.2 Antidepressants(SSRIs)
        4.1.3 Phosphodiesterase-5 Inhibitors
        4.1.4 Topical Anesthetics
        4.1.5 Analgesics
        4.1.6 Other Treatment
    4.2 By Type - Global Premature Ejaculation Treatment Revenue & Forecasts
        4.2.1 By Type - Global Premature Ejaculation Treatment Revenue, 2016-2021
        4.2.2 By Type - Global Premature Ejaculation Treatment Revenue, 2022-2027
        4.2.3 By Type - Global Premature Ejaculation Treatment Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Premature Ejaculation Treatment Market Size, 2021 & 2027
        5.1.2 Hospital
        5.1.3 Retail Pharmacy
        5.1.4 Online Pharmacy
        5.1.5 Other
    5.2 By Application - Global Premature Ejaculation Treatment Revenue & Forecasts
        5.2.1 By Application - Global Premature Ejaculation Treatment Revenue, 2016-2021
        5.2.2 By Application - Global Premature Ejaculation Treatment Revenue, 2022-2027
        5.2.3 By Application - Global Premature Ejaculation Treatment Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global Premature Ejaculation Treatment Market Size, 2021 & 2027
    6.2 By Region - Global Premature Ejaculation Treatment Revenue & Forecasts
        6.2.1 By Region - Global Premature Ejaculation Treatment Revenue, 2016-2021
        6.2.2 By Region - Global Premature Ejaculation Treatment Revenue, 2022-2027
        6.2.3 By Region - Global Premature Ejaculation Treatment Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America Premature Ejaculation Treatment Revenue, 2016-2027
        6.3.2 US Premature Ejaculation Treatment Market Size, 2016-2027
        6.3.3 Canada Premature Ejaculation Treatment Market Size, 2016-2027
        6.3.4 Mexico Premature Ejaculation Treatment Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe Premature Ejaculation Treatment Revenue, 2016-2027
        6.4.2 Germany Premature Ejaculation Treatment Market Size, 2016-2027
        6.4.3 France Premature Ejaculation Treatment Market Size, 2016-2027
        6.4.4 U.K. Premature Ejaculation Treatment Market Size, 2016-2027
        6.4.5 Italy Premature Ejaculation Treatment Market Size, 2016-2027
        6.4.6 Russia Premature Ejaculation Treatment Market Size, 2016-2027
        6.4.7 Nordic Countries Premature Ejaculation Treatment Market Size, 2016-2027
        6.4.8 Benelux Premature Ejaculation Treatment Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia Premature Ejaculation Treatment Revenue, 2016-2027
        6.5.2 China Premature Ejaculation Treatment Market Size, 2016-2027
        6.5.3 Japan Premature Ejaculation Treatment Market Size, 2016-2027
        6.5.4 South Korea Premature Ejaculation Treatment Market Size, 2016-2027
        6.5.5 Southeast Asia Premature Ejaculation Treatment Market Size, 2016-2027
        6.5.6 India Premature Ejaculation Treatment Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America Premature Ejaculation Treatment Revenue, 2016-2027
        6.6.2 Brazil Premature Ejaculation Treatment Market Size, 2016-2027
        6.6.3 Argentina Premature Ejaculation Treatment Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Premature Ejaculation Treatment Revenue, 2016-2027
        6.7.2 Turkey Premature Ejaculation Treatment Market Size, 2016-2027
        6.7.3 Israel Premature Ejaculation Treatment Market Size, 2016-2027
        6.7.4 Saudi Arabia Premature Ejaculation Treatment Market Size, 2016-2027
        6.7.5 UAE Premature Ejaculation Treatment Market Size, 2016-2027
7 Players Profiles
    7.1 Pfizer
        7.1.1 Pfizer Corporate Summary
        7.1.2 Pfizer Business Overview
        7.1.3 Pfizer Premature Ejaculation Treatment Major Product Offerings
        7.1.4 Pfizer Premature Ejaculation Treatment Revenue in Global (2016-2021)
        7.1.5 Pfizer Key News
    7.2 Novartis
        7.2.1 Novartis Corporate Summary
        7.2.2 Novartis Business Overview
        7.2.3 Novartis Premature Ejaculation Treatment Major Product Offerings
        7.2.4 Novartis Premature Ejaculation Treatment Revenue in Global (2016-2021)
        7.2.5 Novartis Key News
    7.3 Eli Lilly
        7.3.1 Eli Lilly Corporate Summary
        7.3.2 Eli Lilly Business Overview
        7.3.3 Eli Lilly Premature Ejaculation Treatment Major Product Offerings
        7.3.4 Eli Lilly Premature Ejaculation Treatment Revenue in Global (2016-2021)
        7.3.5 Eli Lilly Key News
    7.4 Johnson & Johnson
        7.4.1 Johnson & Johnson Corporate Summary
        7.4.2 Johnson & Johnson Business Overview
        7.4.3 Johnson & Johnson Premature Ejaculation Treatment Major Product Offerings
        7.4.4 Johnson & Johnson Premature Ejaculation Treatment Revenue in Global (2016-2021)
        7.4.5 Johnson & Johnson Key News
    7.5 GlaxoSmithKline
        7.5.1 GlaxoSmithKline Corporate Summary
        7.5.2 GlaxoSmithKline Business Overview
        7.5.3 GlaxoSmithKline Premature Ejaculation Treatment Major Product Offerings
        7.5.4 GlaxoSmithKline Premature Ejaculation Treatment Revenue in Global (2016-2021)
        7.5.5 GlaxoSmithKline Key News
    7.6 Bayer
        7.6.1 Bayer Corporate Summary
        7.6.2 Bayer Business Overview
        7.6.3 Bayer Premature Ejaculation Treatment Major Product Offerings
        7.6.4 Bayer Premature Ejaculation Treatment Revenue in Global (2016-2021)
        7.6.5 Bayer Key News
    7.7 Menarini
        7.7.1 Menarini Corporate Summary
        7.7.2 Menarini Business Overview
        7.7.3 Menarini Premature Ejaculation Treatment Major Product Offerings
        7.4.4 Menarini Premature Ejaculation Treatment Revenue in Global (2016-2021)
        7.7.5 Menarini Key News
    7.8 Teva
        7.8.1 Teva Corporate Summary
        7.8.2 Teva Business Overview
        7.8.3 Teva Premature Ejaculation Treatment Major Product Offerings
        7.8.4 Teva Premature Ejaculation Treatment Revenue in Global (2016-2021)
        7.8.5 Teva Key News
    7.9 Sunrise Pharma
        7.9.1 Sunrise Pharma Corporate Summary
        7.9.2 Sunrise Pharma Business Overview
        7.9.3 Sunrise Pharma Premature Ejaculation Treatment Major Product Offerings
        7.9.4 Sunrise Pharma Premature Ejaculation Treatment Revenue in Global (2016-2021)
        7.9.5 Sunrise Pharma Key News
    7.10 Regent Pacific
        7.10.1 Regent Pacific Corporate Summary
        7.10.2 Regent Pacific Business Overview
        7.10.3 Regent Pacific Premature Ejaculation Treatment Major Product Offerings
        7.10.4 Regent Pacific Premature Ejaculation Treatment Revenue in Global (2016-2021)
        7.10.5 Regent Pacific Key News
    7.11 Torrent Pharma
        7.11.1 Torrent Pharma Corporate Summary
        7.11.2 Torrent Pharma Business Overview
        7.11.3 Torrent Pharma Premature Ejaculation Treatment Major Product Offerings
        7.11.4 Torrent Pharma Premature Ejaculation Treatment Revenue in Global (2016-2021)
        7.11.5 Torrent Pharma Key News
    7.12 Vivus
        7.12.1 Vivus Corporate Summary
        7.12.2 Vivus Business Overview
        7.12.3 Vivus Premature Ejaculation Treatment Major Product Offerings
        7.12.4 Vivus Premature Ejaculation Treatment Revenue in Global (2016-2021)
        7.12.5 Vivus Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com